38 Results for "

VCP

" in MedChemExpress (MCE) Product Catalog:
Products (38)

38 Results for "VCP" in MCE Product Catalog:

  • Targets Recommended:
53
53 Publications Verification
Cat. No.: HY-12861
CAS No.: 1542705-92-9
Purity:  99.90%
Target:  

p97

Research Areas:  

Cancer

CB-5083 is a first-in-class, potent, selective, and orally bioavailable inhibitor of the p97 AAA ATPase/VCP. CB-5083 selectively inhibits p97 through its D2 site with the IC50 of 11 nM .
loading...
    loading...
19
19 Cited Publications
Cat. No.: HY-15713
CAS No.: 1418013-75-8
Purity:  99.92%
Target:  

p97

Research Areas:  

Cancer

NMS-873 is a potent, selective allosteric VCP/p97 inhibitor with an IC50 value of 30 nM.
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-157508
CAS No.: 3061959-30-3
Purity:  99.94%
Target:  

p97

Research Areas:  

Others

VCP Activator 1 is a VCP activator that dose-dependently stimulates VCP ATPase activity. VCP Activator 1 binds an allosteric pocket near the C-terminus. In addition, VCP Activator 1 binding site can also be occupied by a phenylalanine residue in the VCP C-terminal tail .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-123872
CAS No.: 2219320-08-6
Purity:  99.89%
Target:  

p97

Research Areas:  

Cancer

MSC1094308 is a non-competitive and reversible VPS4B/p97 (VCP) (I/II type AAA ATPase) allosteric inhibitor, with IC50 values of 0.71 μM and 7.2 μM for VPS4B and p97, respectively . MSC1094308 inhibits the D2 ATPase activity by binding to a agentable hotspot of p97. MSC1094308 can be used in study of cancer .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-15714
CAS No.: 1449236-96-7
Purity:  98.05%
Target:  

p97

Research Areas:  

Cancer

NMS-859 is a potent, covalent VCP (p97) inhibitor, with IC50s of 0.37 and 0.36 μM for wild-type VCP in the presence of 60 μM and 1 mM ATP in cells, respectively.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-139606
CAS No.: 2630950-38-6
Target:  

p97

Research Areas:  

Cancer

VCP/p97 inhibitor-1 is a potent inhibitor of VCP/p97 (also called Cdc48, CDC-. 48, or Ter94) with an IC50 of 54.7 nM. VCP/p97 inhibitor-1 causes the dysregulation of protein homeostasis and disturbs the degradation of misfolded polypeptides by the ubiquitin-proteasome system (UPS) .
loading...
    loading...
Cat. No.: HY-128870
CAS No.: 2130869-18-8
Purity:  99.82%
Research Areas:  

Cancer

Mal-PEG2-VCP-Eribulin consists the ADCs linker (Mal-PEG2-VCP) and Eribulin (HY-13442). Eribulin is a mechanistically unique microtubule inhibitor and Eribulin inhibits the proliferation of cancer cells by binding microtubule proteins and microtubules. Mal-PEG2-VCP-Eribulin is an Eribulin-based agent for antibody conjugates .
loading...
    loading...
Cat. No.: HY-130084
CAS No.: 2395887-69-9
Purity:  98.25%
Target:  

ADC Linkers

Research Areas:  

Cancer

Mal-PEG2-VCP-NB is a claevable ADC linker containing a Maleimide group, 2-unit PEG and a VCP NB.
loading...
    loading...
Cat. No.: HY-168324
CAS No.: 489402-33-7
Target:  

p97

Research Areas:  

Others

UP158 enhances the activity of ATPase, and activates valosin-containing protein (VCP) with an EC50 of 2.57 μM .
loading...
    loading...
Cat. No.: HY-138233
CAS No.: 1357164-52-3
Purity:  99.76%
Target:  

p97

KUS121, a valosin-containing protein (VCP, p97) modulator with significant neuroprotective effects, attenuates ischemic retinal cell death via suppressing endoplasmic reticulum stress .
loading...
    loading...
Cat. No.: HY-168325
CAS No.: 443353-87-5
Target:  

p97

Research Areas:  

Others

UP12 is an ATPase activity activator that activates the ATPase activity of valosin-containing protein (VCP), with an EC50 of 1.24 μM. UP12 is applicable to research related to multisystem proteinopathies .
loading...
    loading...
Cat. No.: HY-RS15621
Research Areas:  

Others

VCP Human Pre-designed siRNA Set A contains three designed siRNAs for VCP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-168323
CAS No.: 591242-60-3
Target:  

p97

Research Areas:  

Others

UP163 enhances the activity of ATPase, and activates valosin-containing protein (VCP) with an EC50 of 9.0 μM. UP163 reduces MG-132 (HY-13259)-induced TDP-43 aggregates .
loading...
    loading...
Cat. No.: HY-128871
CAS No.: 2130869-17-7
Research Areas:  

Cancer

VCP-Eribulin is a bioactive molecule-linker conjugate designed for ADCs (Drug-Linker Conjugates for ADC), formed by conjugating an ADC linker (VCP) with Eribulin (HY-13442). Eribulin is a unique microtubule inhibitor exhibiting antitumor activity. VCP-Eribulin can be utilized for antibody conjugation .
loading...
    loading...
Cat. No.: HY-124776
CAS No.: 696655-62-6
Purity:  99.92%
Target:  

p97

Research Areas:  

Cancer

NPD8733 is an inhibitor of cancer cell-enhanced fibroblast migration. NPD8733 specifically binds to valosin-containing protein (VCP)/p97, a member of the ATPase-associated with diverse cellular activities (AAA+) protein family. NPD8733 has the potential for the research of cancer diseases .
loading...
    loading...
Cat. No.: HY-148122
CAS No.: 2749599-78-6
Target:  

p97

Research Areas:  

Cancer

NW 1028 is a potent VCP/p97 inhibitor. NW 1028 targets the ND1L domain of p97 and inhibits the degradation of a p97-dependent reporter. NW 1028 has good binding affinity with Kd values of 100 and 285 nM for ND1L and full length p97, respectively. NW 1028 has the function of regulating the mitotic spindle of cells .
loading...
    loading...
Cat. No.: HY-174984
CAS No.: 3098437-66-9
Target:  

p97 Caspase p62

Research Areas:  

Cancer

VCP/p97 IN-3 is a VCP/p97 allosteric inhibitor. VCP/p97 IN-3 shows the inhibitory activity against the VCP proteins with an IC50 of 9 nM and the mutant VCP proteins with IC50 of 12 nM (N660K) and 19 nM (V474A/D649A). VCP/p97 IN-3 increases K48-linked ubiquitination and the level of cleaved caspase-3. VCP/p97 IN-3 activates ER-stress and the UPR. VCP/p97 IN-3 inhibits tumor growth in RPMI-8226 cell subcutaneous xenograft mouse models. VCP/p97 IN-3 can be used for the study of multiple myeloma .
loading...
    loading...
Cat. No.: HY-RS15623
Research Areas:  

Others

Vcp Rat Pre-designed siRNA Set A contains three designed siRNAs for Vcp gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-113608
CAS No.: 1018830-99-3
Target:  

Adenosine Receptor

Research Areas:  

Neurological Disease

VCP171 is a potent adenosine A1 receptor (A1R) positive allosteric modulator (PAM). VCP171 is effective at decreasing excitatory synaptic currents in Lamina II of neuropathic pain model. VCP171 can be used for researching neuropathic pain .
loading...
    loading...
Cat. No.: HY-174847
CAS No.: 3007658-94-5
Target:  

p97

Research Areas:  

Cancer

VCP/p97 IN-2 (Compound V13) is a VCP/p97 inhibitor with IC50 of 32 nM for p97. VCP/p97 IN-2 has excellent antitumor activities and significantly inhibits tumor growth in Molm-13 xenograft mice model. VCP/p97 IN-2 can be used for acute myeloid leukemia (AML) research .
loading...
    loading...